Masahide Goto, Ph.D.
Dr. Masahide [Hide] Goto is President of the Astellas Institute for Regenerative Medicine (AIRM). He has 30 years’ experience as a researcher in molecular biology and as a leader for research teams across a wide variety of therapeutic areas, including metabolic and infectious disease, antibodies, nucleic acid medicine and gene therapy-related activities, ophthalmology, and otology.
Dr. Goto joined Astellas as a researcher in molecular medicine in 1997 for Astellas predecessor Yamanouchi Pharmaceutical Co., Ltd. His prior roles at the company include Senior Director, Biologics, Modality Research Laboratory; Executive Director, Candidate Discovery Research Unit 3, Candidate Discovery Science Laboratory; and Executive Director, Eye & Ear Virtual Venture Unit.
Dr. Goto holds a Ph.D. in Biotechnology from the Tokyo Institute of Technology and is the author of nearly 20 scientific papers.